Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open
Scientists of the Laboratory of nano-bioengineering, Engineering-physical Institute of Biomedicine, National research nuclear University «MEPhI» Galina Nifontova, Swisha Maria, Maria Baryshnikova and Igor Nabiev, in collaboration with researchers from MIPT, Institute for experimental medicine max Planck (Germany) and University of Reims champagne-Ardenne (France) has developed polyelectrolyte microcapsules with embedded quantum dots that can be used for the diagnosis and treatment of cancer.
Detailed view of its core may lead to development of targeted drugs
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
Tumor cells circulating throughout the body in blood vessels have long been feared as harbingers of metastasizing cancer — even though most free-floating cancer cells will not go on to establish a new tumor.